PODD Insulet PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: PODD
- PE Ratio
As of May 28, 2025, the Insulet stock's PE ratio is 56.37. This takes into account the latest EPS of $5.74 and stock price of $323.55. The PE ratio marks an increase of 38% from its last 4 quarters average of 41.0.
PODD PE ratio history
The PE ratio of Insulet has averaged 2114.52 over the last seven years. The current P/E ratio of 56.37 is 97% lower than the historical average. Looking back at the last seven years, PODD's PE ratio peaked in the Mar 2023 quarter at 31,896, when the price was $318.96 and the EPS was $0.01. The lowest point was in the Jun 2024 quarter, when it reached 35.72 with a price of $201.8 and an EPS of $5.65.
Insulet PE ratio by year
Maximum annual increase: 295.16% in 2022
Maximum annual decrease: -98.26% in 2023
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 43.73 | -40.34% | $261.07 | $5.97 |
| 2023 | 73.3 | -98.26% | $216.98 | $2.96 |
| 2022 | 4,205.57 | 295.16% | $294.39 | $0.07 |
| 2021 | 1,064.28 | -54.2% | $266.07 | $0.25 |
| 2020 | 2,323.91 | 157.91% | $255.63 | $0.11 |
| 2019 | 901.05 | -31.84% | $171.2 | $0.19 |
| 2018 | 1,322 | N/A | $79.32 | $0.06 |
| 2017 | N/A | N/A | $69 | -$0.46 |
| 2016 | N/A | N/A | $37.68 | -$0.51 |
| 2015 | N/A | N/A | $37.81 | -$1.29 |
| 2014 | N/A | N/A | $46.06 | -$0.92 |
| 2013 | N/A | N/A | $37.1 | -$0.83 |
| 2012 | N/A | N/A | $21.22 | -$1.08 |
| 2011 | N/A | N/A | $18.83 | -$0.98 |
| 2010 | N/A | N/A | $15.5 | -$1.54 |
Insulet PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 45.75 | 4.62% | $262.61 | $5.74 |
| Dec 2024 | 43.73 | 13.11% | $261.07 | $5.97 |
| Sep 2024 | 38.66 | 8.23% | $232.75 | $6.02 |
| Jun 2024 | 35.72 | -30.18% | $201.8 | $5.65 |
| Mar 2024 | 51.16 | -30.2% | $171.4 | $3.35 |
| Dec 2023 | 73.3 | -20.95% | $216.98 | $2.96 |
| Sep 2023 | 92.73 | -71.06% | $159.49 | $1.72 |
| Jun 2023 | 320.38 | -99% | $288.34 | $0.9 |
| Mar 2023 | 31,896 | 658.42% | $318.96 | $0.01 |
| Dec 2022 | 4,205.57 | 358.32% | $294.39 | $0.07 |
| Sep 2022 | 917.6 | 114.73% | $229.4 | $0.25 |
| Jun 2022 | 427.33 | 2.67% | $217.94 | $0.51 |
| Mar 2022 | 416.23 | -60.89% | $266.39 | $0.64 |
| Dec 2021 | 1,064.28 | N/A | $266.07 | $0.25 |
| Sep 2021 | N/A | N/A | $284.23 | -$0.45 |
PODD Price vs fair value
PODD average PE ratio chart
PODD's current PE ratio is lower than its 3, 5 and 10-year averages.
PODD PE vs peers
PODD's PE ratio stands lower than its peer stocks LLY and DXCM, but it is higher than JNJ's and ABT's. Insulet is currently trading at a higher PE ratio (56.37) than its peers average of 36.24.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 16.82 | $366.76B |
| ABT Abbott Laboratories | 17.1 | $229.69B |
| MDT Medtronic plc | 24.54 | $104.19B |
| PODD Insulet Corp | 56.37 | $22.77B |
| LLY ELI LILLY & Co | 58.3 | $681.79B |
| DXCM Dexcom Inc | 64.43 | $34.11B |
| ICUI Icu Medical Inc | N/A | $3.16B |
| DCTH Delcath Systems Inc | N/A | $563.84M |
| TNDM Tandem Diabetes Care Inc | N/A | $1.41B |
Frequently asked questions
What is Insulet's PE ratio?
PODD stock has a price to earnings ratio of 56.37 as of May 28, 2025.
What is the 3-year average PE ratio for Insulet (PODD)?
The average PE ratio for PODD stock over the past 3 years is 3178.99.
What is the 5-year average PE ratio for Insulet (PODD)?
The average PE ratio for PODD stock over the past 5 years is 2501.98.
What is the highest PE ratio for PODD?
Over the last seven years, the quarterly PE ratio reached its highest level at 31,896 in the Mar 2023 quarter.
How does the current PE ratio for PODD compare to its historical average?
PODD's price to earnings ratio is currently 97% below its 7-year historical average.
How is PODD's PE ratio calculated (Insulet PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (May 28, 2025), Insulet's share price is $323.55. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $5.74. Therefore, Insulet's PE ratio for today is 56.37. PE RATIO(56.37) = STOCK PRICE($323.55) / TTM EPS($5.74)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.